Cart
sales@molnova.com
GS-9822
CAS No. 2219362-41-9
GS-9822( GS9822 | GS 9822 )
Catalog No. M13539 CAS No. 2219362-41-9
GS-9822 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1773 | Get Quote |
|
| 50MG | 3582 | Get Quote |
|
| 100MG | 4950 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGS-9822
-
NoteResearch use only, not for human use.
-
Brief DescriptionGS-9822 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 3 nM.
-
DescriptionGS-9822 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 3 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsGS9822 | GS 9822
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2219362-41-9
-
Formula Weight659.242
-
Molecular FormulaC36H39ClN4O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC2=C(C(=C1C(C(=O)O)OC(C)(C)C)C3=CC=C(C=C3)Cl)SC(=N2)C4=CC5=C(C=C4)N(N=C5C6CCN(CC6)C7COC7)C
-
Chemical Name(S)-2-(tert-butoxy)-2-(7-(4-chlorophenyl)-5-methyl-2-(1-methyl-3-(1-(oxetan-3-yl)piperidin-4-yl)-1H-indazol-5-yl)benzo[d]thiazol-6-yl)acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tenofovir alafenamid...
Tenofovir alafenamide fumarate (GS-7340 fumarate) is an orally available precursor of Tenofovir with anti-HIV activity, used to prevent HIV infection.
-
TAT 48-57
TAT (48-57) is a cell-permeable peptide, derived from HIV-1 transactivator of transcription (Tat) protein residue 48-57.This peptide is amino acid residues 48 to 57 fragment of the basic domain of HIV Tat.
-
Deoxyrhapontin
Desoxyrhaponticin and rhaponticin could be considered as promising fatty acid synthase(FAS) inhibitors, they could inhibit intracellular FAS activity and downregulate FAS expression in human breast cancer MCF-7 cells.
